Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “the Company”) (TSXV:NSP) is pleased to announce that Cannabis Compliance Inc. has been retained to prepare the submission for the Company to become a Licensed Dealer of cannabis extracts under the Canadian regulatory regime. Becoming a Licensed Dealer allows the Company to pursue a number of activities related to cannabis and the extraction, formulation and distribution of cannabinoids such as cannabidiol (“CBD”).

Becoming a Licensed Dealer would allow Naturally Splendid to expand Canadian operations and revenue streams to include CBD as well as other cannabinoids, as it relates to extraction, product development, manufacturing and marketing of cannabinoid fortified products. According to the Prime Minister’s office, regulatory laws in Canada pertaining to the extraction of CBD from industrial hemp are anticipated to be amended in the summer of 2018. Becoming a Licensed Dealer positions Naturally Splendid to be a supplier of CBD and CBD fortified products as well as the ability to perform a number of additional services as identified below each in accordance with the Canadian regulatory regime.


The regulatory purpose for a Licensed Dealer is to enable legal possession of controlled substances such as CBD for the following purposes:

1)  Manufacturing
2)  Packaging
3)  Preparation of R&D Formulations for future manufacturing
4)  Resale and distribution to other licensees, including pharmacies
5)  Importing and exporting for global sales
6)  Laboratory testing
7)  Contract activities for any of the above activities

From the R&D and manufacturing perspective, Licensed Dealers are permitted to prepare formulation from cannabis whether that be from hemp or marijuana. On the other hand, Licensed Producers (“LPs”), who are the growers of medical marijuana, are limited to formulations with only carrier oils.  LPs cannot add additives, e.g. flavour, stabilizer or any other ingredient that would be required to manufacture or alter the cannabis product in the form of an edible, Natural Health Products (NHPs), neutraceutical or pharmaceutical products. This is the role of the Licensed Dealer, thus creating business opportunities not available to LPs.

Naturally Splendid CEO Mr. Douglas Mason states, “Retaining Cannabis Compliance to prepare and submit our Dealer License application is a significant move strategically for the Company. A Dealer’s License allows Naturally Splendid to continue to evolve our business, and to execute our strategic plan in preparation for the upcoming amendments to the Canadian MMJ and Industrial hemp regulations anticipated in the summer of 2018. This also allows the Company to position itself as growing global trends towards CBD have become more acceptable, including approval by the World Anti-Doping Association (WADA), that now accepts CBD as an approved ingredient. 2018 will be a pivotal point for Canada and Naturally Splendid as CBD continues to gain acceptance and legal regulation in more than 25 countries around the world. Naturally Splendid intends to be at the forefront of that opportunity utilizing our IP; formulating and processing expertise; and distribution through our existing and developing distribution channels globally in jurisdictions that allow for CBD and CBD fortified products.”

Additionally, a Licensed Dealer application is generally processed much quicker than a license for a Licensed Producer. We anticipate the process to obtain License Dealer status to take approximately four months, which is significantly quicker than the time it takes to obtain a License Producer license.

Cannabis Compliance representative and CFO Mr. Sid Hathiraman states, “We are pleased to work with Naturally Splendid on their application for a Dealers License. Research and Development will be a key differentiator in the cannabis industry and securing a Dealer License is an important step in this direction.”

About Cannabis Compliance Inc.

For over a decade, Cannabis Compliance Inc. (“CCI”) has offered risk mitigation, due diligence and regulatory compliance for commercial cannabis producers and resellers around the world.  Their focus is in the Global market, and they provide their clients with trusted and comprehensive solutions.  CCI has extensive expertise in regulatory compliance, cultivation/horticulture, security designs/tender, facility designs/build-outs, quality assurance programs, Import & Export, staff recruitment and financial planning. They have provided services to several Licensed Producers as well as ‘industry companies’, resulting in the successful granting of licenses.

As reported in a previous news release:
In an article from WholeFoods Magazine in 2018 Sean Murphy, Founder, Hemp Business Journal, offered his opinions on where hemp is heading in the coming year. Hemp Business Journal estimates the hemp industry will grow to $1.8 billion in sales by 2020, led by hemp food, body care and CBD-based products. The data demonstrates that the hemp industry is growing quickly at 22% 5-year CAGR and being led by food and body care products.

This is a big year for hemp-derived CBD, especially in Canada. The country is on its way to legalizing CBD nationwide in 2018. Some expect sales of this product that don’t get you high will reach $3 billion in the next five years. Canada has proposed changes to hemp regulations allowing for the extraction of CBD, limiting to 10 ppm the amount of psychoactive THC they can contain.

  • The Hemp Business Journal estimated that the CBD market will grow to a $2.1 billion market in consumer sales by 2020 with $450 million of those sales coming from hemp-based sources. That’s a 700% increase from 2016.
  • In 2015, the market for consumer sales of hemp-derived CBD products was $90 million, plus another $112 million in marijuana-derived CBD products which were sold through dispensaries – bringing a total CBD market to $202 million last year.
  • The hemp CBD market has reached an estimated retail value of $130 million in the United States alone, according to a 2016 market estimate by Vote Hemp and the Hemp Business Journal. A spokesman for Vote Hemp also estimated there are likely 50-100 hemp cannabidiol brands, along with hundreds more growers and processors that focus on hemp-based CBD.

About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp and non-psychoactive cannabinoid compounds in a broad spectrum of applications.

Naturally Splendid currently has four innovative divisions:

(1) BIOTECHNOLOGY –  Focused on three major platforms:

  (1) Proprietary HempOmega™ encapsulation

  (2) Extraction and formulation with Cannabidiol (CBD)

  (3) Hemp and plant-based proteins.

  • POS-BPC Facility – a 12,000-square-foot production facility leased and operated by POS BPC Manufacturing Inc., a company jointly owned by NSE (51%) and POS Holdings (49%), offers commercial-scale custom processing solutions for functional foods and natural health.

(2) CONSUMER PRODUCTS –

  • NATERA® – brand of retail hemp and superfood products distributed throughout North America, Asia and Europe.
  • Prosnack Natural Foods Inc. (Elevate Me™) – lifestyle brand of healthy meal replacement products distributed throughout North America.
  • Chi Hemp Industries Incorporated (CHII) – e-commerce platform for natural and organic hemp products.
  • PawsitiveFX® – topical pet care products.
  • NATERA®CBD – retail hemp-based cannabinoid nutraceutical and cosmeceutical products distributed in Asia.
  • NATERA®Skincare – brand of retail hemp based cosmeceutical products.

(3) NATERA® Ingredients – bulk ingredients including HempOmega™.

(4) Co-Packaging/Toll-Processing – packaging for house-brands (NATERA® and CHII) and third-party partners.

For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-673-9573

On Behalf of the Board of Directors

Mr. Doug Mason
CEO, Director

Contact Information

Naturally Splendid Enterprises Ltd.
(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office: (604) 465-0548
Fax: (604) 465-1128
E-mail: info@naturallysplendid.com
Website: www.naturallysplendid.com

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to become a Licensed Dealer, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Click here to connect with Naturally Splendid (TSXV:NSP) and receive an Investors Presentation.

Source: globenewswire.com

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Trading resumes in:

Company: 4Front Ventures Corp.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /

  4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) is pleased to announce that it has completed its previously announced bought deal prospectus offering (the ” Offering “) of units of the Company (” Units “), for aggregate gross proceeds of C$17,251,150 including full exercise of the over-allotment option granted to the underwriters in connection therewith.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff

Tactile Systems Technology (NASDAQ:TCMD)
Class Period:
May 7, 2018 – June 8, 2020
Deadline: November 30, 2020
For more info: www.bgandg.com/tcmd

Keep reading... Show less

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), announced today that it has re-filed its unaudited condensed interim consolidated financial statements, together with the notes thereto, for the three and six months ended June 30, 2020 and 2019 (the “ Interim Financial Statements ”) to correct, among other things, certain 2019 comparative period information and to update certain presentation arising from the Company’s early adoption of IFRS 3 in late 2019, which changes were identified in connection with the Company’s review engagement with its auditor. The Company does not consider these adjustments either individually nor in the aggregate, to be material.

The re-filed Interim Financial Statements reflect changes to the Condensed Interim Consolidated Statements of Loss and Comprehensive Loss comparative period to remove transaction fees from the income statement and capitalize them to the applicable acquisition in accordance with the Company’s early adoption of the amended IFRS 3 as set out in Note 2, and to reclassify $1 million from general and administrative expenses to transaction fees for presentation purposes to conform with the Company’s presentation used in its audited consolidated financial statements for the years ended December 31, 2019 and 2018 (the “ Audited Annual Financial Statements ”). The re-filed interim Financial Statements also reflect changes to the Condensed Interim Consolidated Statement of Changes in Shareholders’ Equity to correct the 2019 comparative period balances as they incorrectly reflect Q1 2019 period balances, update certain presentation to conform with the Company’s presentation used in its Audited Annual Financial Statements; and reduce the valuation conclusion of the Company’s acquisition of NettaGrowth International Inc. to conform with the Audited Annual Financial Statements. The re-filed Interim Financial Statements also bring forward the subsequent event note disclosure.

Keep reading... Show less